26
Participants
Start Date
May 28, 2020
Primary Completion Date
August 26, 2020
Study Completion Date
August 26, 2020
LY3819253
Administered IV.
Placebo
Administered IV.
Alexandria Center for Life - NYC/ NYCEDC, New York
Temple Univ School of Med, Philadelphia
University of North Carolina, Chapel Hill
Unified Research Enterprise Brody School of Medicine at ECU, Greenville
Emory University, Atlanta
University of Michigan, Ann Arbor
Quality Clinical Research, Inc., Omaha
Cedars Sinai Medical Center, Los Angeles
Veterans Affairs Medical Center San Diego, San Diego
Massachusetts General Hospital, Boston
University of Massachusetts Medical Center, Worcester
Collaborators (1)
AbCellera Biologics Inc.
INDUSTRY
Eli Lilly and Company
INDUSTRY